Keyphrases
Respiratory Syncytial Virus
100%
Hematopoietic Stem Cell Transplantation
100%
Solid Organ Transplantation
100%
Disease Progression
66%
Risk Factors
33%
Polymerase Chain Reaction
33%
Respiratory Infection
33%
Clinical Trials
33%
Viral
33%
Patient Demographics
33%
High Risk
33%
Hematopoietic Stem Cells
33%
New Agents
33%
Pooled Analysis
33%
Viral Antigens
33%
Clinical Course
33%
Prospective Randomized Trial
33%
Ribavirin
33%
Lower Respiratory Tract Infection
33%
Aerosolized
33%
Most Common Cause
33%
Early Diagnosis
33%
Solid Organ Transplant Recipients
33%
High Sensitivity
33%
Lower Respiratory Tract
33%
Medical Intervention
33%
Lymphopenia
33%
Immunocompetent Individual
33%
Viral Culture
33%
Disease Risk
33%
Immunomodulatory Therapy
33%
Risk of Progression
33%
Post-transplant Period
33%
Pulmonary Morbidity
33%
HSCT Recipient
33%
Medicine and Dentistry
Human Respiratory Syncytial Virus
100%
Hematopoietic Stem Cell Transplantation
100%
Solid Organ Transplantation
100%
Lower Respiratory Tract
66%
Transplantation
33%
Disease
33%
Disease Exacerbation
33%
Polymerase Chain Reaction
33%
Respiratory Tract Infection
33%
Infection
33%
Immunomodulating Agent
33%
Clinical Trial
33%
Virus Antigen
33%
Hematopoietic Stem Cell
33%
Pooled Analysis
33%
Disease Course
33%
Ribavirin
33%
Early Diagnosis
33%
Patient Population
33%
Medical Intervention
33%
Respiratory Disease
33%
Lymphocytopenia
33%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
100%
Solid Organ Transplantation
100%
Human Respiratory Syncytial Virus
100%
Lower Respiratory Tract
66%
Virus Antigen
33%
Polymerase Chain Reaction
33%
Transplant Procedure
33%
Hematopoietic Stem Cell
33%
Lymphocytopenia
33%
Immunomodulating Drugs
33%
Ribavirin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
100%
Infection
33%
Disease Exacerbation
33%
Disease
33%
Clinical Trial
33%
Immunomodulating Agent
33%
Virus Antigen
33%
Respiratory Tract Infection
33%
Respiratory Tract Disease
33%
Respiratory Tract
33%
Disease Course
33%
Ribavirin
33%
Lymphocytopenia
33%